International Clinical Trial: A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral PRX-101 in healthy participants (Part 2)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000895482) titled 'A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral PRX-101 in healthy participants (Part 2)' on Aug. 18.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Crossover

Primary Sponsor: Phocus Pharmaceuticals, Inc.

Condition: paroxysmal supraventricular tachycardia paroxysmal supraventricular tachycardia Cardiovascular - Other cardiovascular diseases

Intervention: Part 2 has two stages. It is estimated that 18 to 48 participants will be enrolled in Part 2. The final number...